Verition Fund Management »

Inhibrx Biosciences shares owned by Verition Fund Management

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.7M 18k 94.75

More positions owned by Verition Fund Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Warner Bros Discovery Com Ser A (WBD)
Electronic Arts (EA)
Norfolk Southern (NSC)
Vaneck Etf Trust Semiconductr Etf (SMH)
Select Medical Holdings Corporation
Micron Technology (MU)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Aon Shs Cl A (AON)
Advanced Micro Devices (AMD)

View all positions for Verition Fund Management

Top funds holding Inhibrx Biosciences

Perceptive Advisors
Morgan Stanley
Sanofi
Viking Global Investors
HighTower Advisors
Bank of America Corporation
BlackRock
Schonfeld Strategic Advisors
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Woodline Partners
Capital Research Global Investors
Partner Fund Management
Sofinnova Ventures

View all funds holding Inhibrx Biosciences